The Andrew Bridgen MP speech in the House of Commons recently most definitely does not bode well for the pharmaceutical sector...
I wonder how much of this information is priced in to the likes of Pfizer (NYQ:PFE) for example. How many people are even aware of this parliamentary event or the data being presented, the media hasn't been covering any of this and its been going on for a long while now.
